Relative and absolute risk

Last updated: November 01, 2022

Relative and absolute risk

Step 2

Step 2

Pharyngeal arches, pouches, and clefts
Adrenocorticotropic hormone
Growth hormone and somatostatin
Cortisol
Estrogen and progesterone
Testosterone
Phosphate, calcium and magnesium homeostasis
Vitamin D
Parathyroid hormone
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Mean, median, and mode
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Odds ratio
Relative and absolute risk
Cross sectional study
Cohort study
Case-control study
Randomized control trial
Confounding
Selection bias
Gastrointestinal hormones
Congenital gastrointestinal disorders: Pathology review
Esophageal disorders: Pathology review
Inflammatory bowel disease: Pathology review
Malabsorption syndromes: Pathology review
Gastrointestinal bleeding: Pathology review
Colorectal polyps and cancer: Pathology review
Gallbladder disorders: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Laxatives and cathartics
Acid reducing medications
Antidiarrheals
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Coagulation (secondary hemostasis)
Non-hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Platelet disorders: Pathology review
Coagulation disorders: Pathology review
Macrocytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Plasma cell disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Platinum containing medications
Microtubule inhibitors
Monoclonal antibodies
Topoisomerase inhibitors
Anti-tumor antibiotics
DNA alkylating medications
Antimetabolites for cancer treatment
Lung volumes and capacities
Anatomic and physiologic dead space
Combined pressure-volume curves for the lung and chest wall
Diffusion-limited and perfusion-limited gas exchange
Alveolar gas equation
Oxygen-hemoglobin dissociation curve
Oxygen binding capacity and oxygen content
Carbon dioxide transport in blood
Pulmonary changes at high altitude and altitude sickness
Pulmonary changes during exercise
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Tuberculosis: Pathology review
Pneumonia: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Lung cancer and mesothelioma: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Development of the reproductive system
Menstrual cycle
Menopause
Pregnancy
Oxytocin and prolactin
Breastfeeding
Puberty and Tanner staging
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Breast cancer: Pathology review
Benign breast conditions: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Androgens and antiandrogens
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors
Estrogens and antiestrogens
Uterine stimulants and relaxants
Progestins and antiprogestins
Aromatase inhibitors

Transcript

Watch video only

Risk is the probability of an event occurring - for example let’s say that we’re talking about the risk of being struck by lightning.

You might want to know - your chance of being struck by lightning - that would be the absolute risk. You might also want to know your chance of getting struck by lightning if you’re sipping hot chocolate under a blanket in your bed, versus your chance if you’re out flying a kite in a storm.

Now, let’s say that the kite-fliers are at higher risk then the chocolate-sippers of getting struck by lightning.

Well - you may want to know how many times higher is the risk - the risk ratio, or how much higher is the risk - the risk difference.

So let’s use some numbers to make this concrete. Say we have 400 people in the lightening study - imagine the incentives you’d need to get folks to sign up for that study.

So, let’s say that 200 of the people are sent out to fly a kite in a terrible storm, while the other 200 are sent indoors with a cup of hot chocolate and a blanket.

Now let’s say that 50 of the kite-fliers are struck by lighting.

Based on that data, the absolute risk of being struck by lightning if you’re out flying a kite is the number of lightning strikes, which is 50, divided by the number of people in the group, which is 200.

So, 50/200 or 0.25 is answer - a 25% risk.

Absolute risk = Number of events in a group / individuals in that group

While all that is happening, let’s say that 10 unfortunate chocolate-sipper also gets struck by lightning while sitting under a blanket.

Based on that data, the absolute risk of being struck by lightning if you’re sipping chocolate inside is the number of lightning strikes, which is 10, divided by the number of people in the group, which is 200.

So, 10/200 or 0.05 is answer - a 5% risk.

If you want to compare these two risks, you could say that the relative risk or risk ratio, is the risk in one group, let’s call that group A, divided by the risk in another group, let’s call that group B.

In this case that means 0.25 / 0.05 or a relative risk of 5.

Put differently, When you go outside to fly a kite, your risk of getting hit by lightning is 5 times the risk of getting hit by lightning if you just stayed in and drank that hot chocolate!

Risk ratio or relative risk = Risk in group A / Risk in group B

Now, you may want to know what the risk difference is in absolute terms, this is also called the absolute risk reduction.

Key Takeaways

Risk is the probability of an event occurring, for example, the risk of being struck by lightning. Absolute risk refers to the actual probability of an outcome occurring in a specific group regardless of any other factors. In this case, it would be the chance of being struck by lightning. Relative risk on the other hand, compares the risk of an outcome between exposed and unexposed groups. In this case, it would be the risk of being struck by lightning when flying a kite in a storm, versus when sitting still in a house.